|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
JPS6192592A
(ja)
|
1984-10-12 |
1986-05-10 |
Norin Suisansyo Shokuhin Sogo Kenkyusho |
分岐サイクロデキストリンの製造方法
|
|
US5032392A
(en)
|
1986-09-04 |
1991-07-16 |
Vision Pharmaceuticals |
Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
|
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
AU8942491A
(en)
|
1990-10-22 |
1992-05-20 |
Bausch & Lomb Incorporated |
Method and composition for cleaning contact lenses
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
|
JP2746832B2
(ja)
|
1993-05-14 |
1998-05-06 |
大鵬薬品工業株式会社 |
眼局所抗アレルギー剤
|
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
|
FR2742053B1
(fr)
|
1995-12-06 |
1998-03-06 |
Chauvin Lab Sa |
Compositions pharmaceutiques a base de mequitazine
|
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
|
US6492520B1
(en)
|
1996-08-06 |
2002-12-10 |
Pfizer Inc |
Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
|
|
WO1998050372A1
(de)
|
1997-05-02 |
1998-11-12 |
Schering Aktiengesellschaft |
Substituierte heterocyclen und deren verwendung in arzneimitteln
|
|
EP1012151B1
(en)
|
1997-09-02 |
2002-08-07 |
Bristol-Myers Squibb Pharma Company |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
|
|
JP3568108B2
(ja)
|
1999-07-28 |
2004-09-22 |
松下電器産業株式会社 |
デジタル地図の位置情報伝達方法とそれを実施する装置
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
|
WO2004069157A2
(en)
|
2003-01-17 |
2004-08-19 |
Ophthalmic Research Associates, Inc. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
|
EP2301549A1
(en)
|
2003-04-18 |
2011-03-30 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
JP2005132834A
(ja)
|
2003-10-09 |
2005-05-26 |
Kyowa Hakko Kogyo Co Ltd |
キノリン誘導体
|
|
KR20060109947A
(ko)
|
2003-11-20 |
2006-10-23 |
오쎄라 파마슈티걸즈, 인크. |
황반 변성 및 다른 안과 질환의 개선
|
|
JP2005187407A
(ja)
|
2003-12-25 |
2005-07-14 |
Lion Corp |
アレルギー眼疾患用眼科組成物
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
JP2006008568A
(ja)
|
2004-06-24 |
2006-01-12 |
Cyclochem:Kk |
ＩｇＥ抗体抑制剤および食品
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
FR2875409B1
(fr)
|
2004-09-17 |
2010-05-07 |
Sanofi Aventis |
Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose
|
|
EP1893174A2
(en)
|
2005-05-10 |
2008-03-05 |
Cytophil, Inc. |
Injectable hydrogels and methods of making and using same
|
|
PT1888548E
(pt)
|
2005-05-26 |
2012-10-30 |
Neuron Systems Inc |
Derivado de quinolina para o tratamento de doenças da retina
|
|
US8435965B2
(en)
|
2005-12-27 |
2013-05-07 |
Lion Corporation |
Composition for soft contact lens and adsorption suppressing method
|
|
US20070297981A1
(en)
|
2006-01-25 |
2007-12-27 |
Ousler George W Iii |
Formulations and methods for treating dry eye
|
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
|
RU2434630C2
(ru)
|
2006-08-31 |
2011-11-27 |
Юранд, Инк. |
Системы доставки лекарственных средств, включающие в себя твердые растворы слабоосновных лекарственных средств
|
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
|
MX2010003667A
(es)
|
2007-10-05 |
2010-09-28 |
Acucela Inc |
Compuestos alcoxi para el tratamiento de enfermedades.
|
|
CN102177157A
(zh)
|
2008-08-12 |
2011-09-07 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并*唑类、苯并噻唑类和相关的类似物
|
|
JP5773877B2
(ja)
|
2008-10-22 |
2015-09-02 |
アキュセラ インコーポレイテッド |
眼の疾患及び障害を治療する化合物
|
|
AU2010226249A1
(en)
|
2009-03-17 |
2011-10-13 |
Aciex Therapeutics, Inc. |
Ophthalmic formulations of ketotifen and methods of use
|
|
WO2010141834A1
(en)
|
2009-06-05 |
2010-12-09 |
Aciex Therapeutics, Inc. |
Ophthalmic formulations of fluticasone and methods of use
|
|
EP2477594A4
(en)
|
2009-07-15 |
2013-03-13 |
Univ Vanderbilt |
ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY
|
|
EP2509596B1
(en)
|
2009-12-08 |
2019-08-28 |
Case Western Reserve University |
Gamma aminoacids for treating ocular disorders
|
|
WO2011072141A1
(en)
|
2009-12-11 |
2011-06-16 |
Neuron Systems, Inc. |
Compositions and methods for the treatment of macular degeneration
|
|
CA2788440A1
(en)
|
2010-02-26 |
2011-09-01 |
Xenon Pharmaceuticals Inc. |
Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
|
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
|
CN103442735B
(zh)
|
2011-01-31 |
2016-11-09 |
特米拉公司 |
用于减轻技术领域中所不希望的医学状况的有效要素
|
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
|
|
WO2015187942A1
(en)
|
2014-06-04 |
2015-12-10 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
|
US20130190500A1
(en)
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
EP2916827B1
(en)
|
2012-11-08 |
2020-06-10 |
Clearside Biomedical Inc. |
Methods for the treatment of ocular disease in human subjects
|
|
RU2015120478A
(ru)
|
2012-12-20 |
2017-01-25 |
Альдейра Терапьютикс, Инк. |
Пери-карбинолы
|
|
CA2898631C
(en)
|
2013-01-23 |
2023-06-13 |
Aldeyra Therapeutics, Inc. |
Toxic aldehyde related diseases and treatment
|
|
SG11201505599YA
(en)
|
2013-01-25 |
2015-08-28 |
Aldeyra Therapeutics Inc |
Novel traps in the treatment of macular degeneration
|
|
US20160151410A1
(en)
|
2013-07-02 |
2016-06-02 |
The Trustees Of Columbia University In The City Of New York |
Clearance of bioactive lipids from membrane structures by cyclodextrins
|
|
TW201628622A
(zh)
|
2014-11-17 |
2016-08-16 |
製藥公司 |
Tlr抑制劑與布魯頓氏(bruton's)酪胺酸激酶抑制劑之組合
|
|
WO2016085939A2
(en)
|
2014-11-24 |
2016-06-02 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
KR20180073553A
(ko)
|
2015-08-21 |
2018-07-02 |
알데이라 테라퓨틱스, 아이엔씨. |
알데히드 접합체 및 이의 용도
|
|
CN118724806A
(zh)
|
2015-08-21 |
2024-10-01 |
奥尔德拉医疗公司 |
氘化化合物和其用途
|
|
CA3016759A1
(en)
*
|
2016-02-28 |
2017-08-31 |
Aldeyra Therapeutics, Inc. |
Treatment of allergic eye conditions with cyclodextrins
|
|
US11129823B2
(en)
|
2016-05-09 |
2021-09-28 |
Aldeyra Therapeutics, Inc. |
Combination treatment of ocular inflammatory disorders and diseases
|
|
AU2017317529A1
(en)
|
2016-08-22 |
2019-02-21 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and methods of use thereof
|
|
JP2019532029A
(ja)
|
2016-08-22 |
2019-11-07 |
アルデイラ セラピューティクス， インコーポレイテッド |
アルデヒド補足化合物およびその使用
|
|
US11510931B2
(en)
|
2016-09-28 |
2022-11-29 |
Medicon Pharmaceuticals, Inc. |
Compositions and methods for treating ophthalmic conditions
|
|
MX2019010576A
(es)
|
2017-03-16 |
2019-10-07 |
Aldeyra Therapeutics Inc |
Compuestos polimorficos y usos de los mismos.
|
|
JP7311162B2
(ja)
|
2017-10-10 |
2023-07-19 |
アルデイラ セラピューティクス， インコーポレイテッド |
炎症性障害の処置
|
|
WO2020018498A1
(en)
|
2018-07-16 |
2020-01-23 |
Aldeyra Therapeutics, Inc. |
Cyclodextrin formulations
|
|
WO2020028820A1
(en)
|
2018-08-03 |
2020-02-06 |
Aldeyra Therapeutics, Inc. |
Topical compositions and methods of preparation and use
|
|
WO2020033344A1
(en)
|
2018-08-06 |
2020-02-13 |
Aldeyra Therapeutics, Inc. |
Polymorphic compounds and uses thereof
|
|
EP3856478A4
(en)
|
2018-09-25 |
2022-06-08 |
Aldeyra Therapeutics, Inc. |
FORMULATIONS FOR THE TREATMENT OF DRY EYE
|
|
WO2020072621A1
(en)
|
2018-10-02 |
2020-04-09 |
Aldeyra Therapeutics, Inc. |
Contact lens solutions and kits
|
|
JP2022511030A
(ja)
|
2018-12-05 |
2022-01-28 |
アルデイラ セラピューティクス， インコーポレイテッド |
注射可能な製剤
|
|
US12098132B2
(en)
|
2019-05-02 |
2024-09-24 |
Aldeyra Therapeutics, Inc. |
Process for preparation of aldehyde scavenger and intermediates
|
|
CN113784954A
(zh)
|
2019-05-02 |
2021-12-10 |
奥尔德拉医疗公司 |
多晶型化合物和其用途
|
|
WO2021195211A1
(en)
|
2020-03-24 |
2021-09-30 |
Aldeyra Therapeutics, Inc. |
Quinoline compounds for treating respiratory disorders and viral infections
|
|
EP4135697A4
(en)
|
2020-04-13 |
2024-05-15 |
Aldeyra Therapeutics, Inc. |
Quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditions
|
|
CA3175856A1
(en)
|
2020-05-13 |
2021-11-18 |
Todd Brady |
Pharmaceutical formulations and uses thereof
|
|
US20230228744A1
(en)
|
2020-06-04 |
2023-07-20 |
Aldeyra Therapeutics, Inc. |
Dry eye disease biomarkers and their use for treatment
|
|
US20220211691A1
(en)
|
2021-01-07 |
2022-07-07 |
Aldeyra Therapeutics, Inc. |
Treatment of dry eye disease
|